scispace - formally typeset
Open AccessJournal ArticleDOI

Cytokine Storm.

David C. Fajgenbaum, +1 more
- 03 Dec 2020 - 
- Vol. 383, Iss: 23, pp 2255-2273
Reads0
Chats0
TLDR
From the Department of Medicine, Division of Translational Medicine and Human Genetics, Center for Cytokine Storm Treatment and Laboratory, and the Center for Cellular Immunotherapies and the Parker Institute for Cancer Immunotherapy, University of Pennsylvania, Philadelphia.
Abstract
From the Department of Medicine, Division of Translational Medicine and Human Genetics, Center for Cytokine Storm Treatment and Laboratory (D.C.F.), and the Center for Cellular Immunotherapies and the Parker Institute for Cancer Immunotherapy (C.H.J.), Perelman School of Medicine, University of Pennsylvania, Philadelphia. Address reprint requests to Dr. Fajgenbaum at davidfa@ pennmedicine . upenn . edu or to Dr. June at cjune@ upenn . edu.

read more

Content maybe subject to copyright    Report

Citations
More filters
Journal ArticleDOI

Interleukin-6 Receptor Antagonists in Critically Ill Patients with Covid-19.

TL;DR: In this paper, the authors evaluated tocilizumab and sarilumab in an ongoing international, multifactorial, adaptive platform trial, which used a Bayesian statistical model with predefined criteria for superiority, efficacy, equivalence or futility.
Journal ArticleDOI

Endothelial dysfunction and immunothrombosis as key pathogenic mechanisms in COVID-19.

TL;DR: In this paper, the authors proposed that SARS-CoV-2 infection induces a process known as immunothrombosis, in which activated neutrophils and monocytes interact with platelets and the coagulation cascade, leading to intravascular clot formation in small and larger vessels.
Journal ArticleDOI

COVID-19 and the human innate immune system.

TL;DR: In this article, a conceptual framework for the interaction of the human innate immune system with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was provided to link the clinical observations with experimental findings that have been made during the first year of the pandemic.
Journal ArticleDOI

The signal pathways and treatment of cytokine storm in COVID-19.

TL;DR: In this paper, the authors discuss the latest developments in the immunopathological characteristics of COVID-19 and focus on CS including the current research status of the different cytokines involved, and discuss the induction, function, downstream signaling and existing and potential interventions for targeting these cytokines or related signal pathways.
References
More filters
Journal ArticleDOI

Acute encephalopathy associated with influenza and other viral infections

TL;DR: Various syndromes of acute encephalopathy are reviewed by classifying them into three major categories, caused by metabolic derangement, which includes Reye‐like syndrome, hemorrhagic shock and encephalitis syndrome, and acute necrotizing encephalopathic syndrome.
Journal ArticleDOI

The Immunology of Macrophage Activation Syndrome.

TL;DR: In addition to broadly immunosuppressive therapies, novel cytokine targeted treatments are being explored to dampen the overly active immune response that is responsible for much of the pathology seen in MAS.
Journal ArticleDOI

Alpha-7 nicotinic receptor agonists: potential new candidates for the treatment of schizophrenia

TL;DR: Alpha-7 nicotinic receptor agonists appear to be reasonable candidates for the treatment of cognitive and perceptual disturbances in schizophrenia.
Journal Article

Tumor necrosis factor and endotoxin induce similar metabolic responses in human beings.

TL;DR: TNF may represent the primary afferent signal that initiates many of the metabolic responses associated with sepsis and endotoxemia.
Journal ArticleDOI

The platelet-activating factor signaling system and its regulators in syndromes of inflammation and thrombosis.

TL;DR: Evidence from in vitro experiments, studies of experimental animals, and clinical observations in humans indicates that the PAF signaling system is important in sepsis and other syndromes of inflammatory injury and that therapeutic strategies to interrupt or terminate signaling via the PAf signaling system may be useful in these conditions.
Related Papers (5)